Research and analysis

Synthetic cathinones: an updated harms assessment

ACMD has written an updated harms assessment describing the use and harms of synthetic cathinones following a government commission.

• From: Advisory Council on the Misuse of Drugs
• Published: 3 February 2025
• Last updated: 12 February 2025 — See all updates

Documents

Synthetic cathinones: an updated harms assessment (accessible)

HTML

Synthetic cathinones: an updated harms assessment

PDF, 1.82 MB, 125 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email alternativeformats@homeoffice.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Cover letter from ACMD with advice on synthetic cathinones (accessible)

HTML

Cover letter from ACMD with advice on synthetic cathinones

PDF, 854 KB, 21 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email alternativeformats@homeoffice.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

The ACMD was commissioned in May 2023 by the previous Minister of State for Crime, Policing and Fire to provide an updated harms assessment of 3’,4’-Methylenedioxy-α-pyrrolidinohexiophenone (MDPHP) and other synthetic cathinones under the Misuse of Drugs Act 1971.

The report considers the harms and control of synthetic cathinones and includes recommendations to reduce their harms across the UK.

Published 3 February 2025
Last updated 12 February 2025 + show all updates

1. 12 February 2025

   Added accessible versions.

2. 3 February 2025

   First published.